Stock Information
Travere Therapeutics Inc (TVTX)
Ticker Symbol: TVTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,070.58 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.50
Revenue (TTM): $6.33 M
Dividend Yield: N/A
ROE: -55.79%
Latest News
-
Guggenheim Maintains Buy on Travere Therapeutics, Raises Price Target to $89
Thu, Sep 24, 2026 8:56 AM
-
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis
Wed, Sep 23, 2026 11:00 AM
-
Travere Therapeutics (TVTX) Sets CEO Handover For December 2026
Wed, Sep 23, 2026 1:13 AM
-
SBIO: Big Pharma Needs What This Fund Owns
Tue, Sep 22, 2026 2:17 PM
-
Travere Therapeutics (TVTX) Stock May Trade Above Fair Value Today
Tue, Sep 22, 2026 2:13 PM
-
Wedbush Reiterates Outperform on Travere Therapeutics, Maintains $76 Price Target
Tue, Sep 22, 2026 8:38 AM
-
HC Wainwright & Co. Reiterates Buy on Travere Therapeutics, Maintains $67 Price Target
Tue, Sep 22, 2026 6:29 AM
Key Financials
Financial data not available
